Bayona J - Search Results

1

Contact investigations as a means of detection and timely treatment of persons with infectious multidrug-resistant tuberculosis.

Bayona J, Chavez-Pachas AM, Palacios E, Llaro K, Sapag R, Becerra MC. Bayona J, et al. Int J Tuberc Lung Dis. 2003 Dec;7(12 Suppl 3):S501-9. Int J Tuberc Lung Dis. 2003. PMID: 14677844

2

Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru.

Chavez Pachas AM, Blank R, Smith Fawzi MC, Bayona J, Becerra MC, Mitnick CD. Chavez Pachas AM, et al. Among authors: bayona j. Int J Tuberc Lung Dis. 2004 Jan;8(1):52-8. Int J Tuberc Lung Dis. 2004. PMID: 14974746

3

Drug resistance trends among previously treated tuberculosis patients in a national registry in Peru, 1994-2001.

Vásquez-Campos L, Asencios-Solis L, Leo-Hurtado E, Quispe-Torres N, Salazar-Lindo E, Bayona J, Becerra MC. Vásquez-Campos L, et al. Among authors: bayona j. Int J Tuberc Lung Dis. 2004 Apr;8(4):465-72. Int J Tuberc Lung Dis. 2004. PMID: 15141740

4

Retreatment management strategies when first-line tuberculosis therapy fails.

Saravia JC, Appleton SC, Rich ML, Sarria tM, Bayona J, Becerra MC. Saravia JC, et al. Among authors: bayona j. Int J Tuberc Lung Dis. 2005 Apr;9(4):421-9. Int J Tuberc Lung Dis. 2005. PMID: 15830748

5

HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.

Palacios E, Franke M, Muñoz M, Hurtado R, Dallman R, Chalco K, Guerra D, Mestanza L, Llaro K, Bonilla C, Sebastian J, Bayona J, Lygizos M, Anger H, Shin S. Palacios E, et al. Among authors: bayona j. Int J Tuberc Lung Dis. 2012;16(3):348-54. doi: 10.5588/ijtld.11.0473. Int J Tuberc Lung Dis. 2012. PMID: 22640448

6

Presumptive treatment of multidrug-resistant tuberculosis in household contacts.

Parr JB, Rich ML, Keshavjee S, Franke MF, Mitnick CD, Bayona J, Becerra MC. Parr JB, et al. Among authors: bayona j. Int J Tuberc Lung Dis. 2016 Mar;20(3):370-5. doi: 10.5588/ijtld.15.0433. Int J Tuberc Lung Dis. 2016. PMID: 27046719

7

Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB.

Rich ML, Socci AR, Mitnick CD, Nardell EA, Becerra MC, Bonilla C, Bayona J, Seung KJ, Furin J, Farmer PE, Mukherjee JS. Rich ML, et al. Among authors: bayona j. Int J Tuberc Lung Dis. 2006 Mar;10(3):290-6. Int J Tuberc Lung Dis. 2006. PMID: 16562709

8

Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.

Becerra MC, Freeman J, Bayona J, Shin SS, Kim JY, Furin JJ, Werner B, Sloutsky A, Timperi R, Wilson ME, Pagano M, Farmer PE. Becerra MC, et al. Among authors: bayona j. Int J Tuberc Lung Dis. 2000 Feb;4(2):108-14. Int J Tuberc Lung Dis. 2000. PMID: 10694087

9

Redefining MDR-TB transmission 'hot spots'.

Becerra MC, Bayona J, Freeman J, Farmer PE, Kim JY. Becerra MC, et al. Among authors: bayona j. Int J Tuberc Lung Dis. 2000 May;4(5):387-94. Int J Tuberc Lung Dis. 2000. PMID: 10815730

10

Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis.

Furin JJ, Mitnick CD, Shin SS, Bayona J, Becerra MC, Singler JM, Alcantara F, Castañieda C, Sanchez E, Acha J, Farmer PE, Kim JY. Furin JJ, et al. Among authors: bayona j. Int J Tuberc Lung Dis. 2001 Jul;5(7):648-55. Int J Tuberc Lung Dis. 2001. PMID: 11467371

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

306 results

Search Page

Filters